Select area of interest:
Manufacturing Chemist: CARBOGEN AMCIS Featured for Expertise in High-Potency Formulations
CARBOGEN AMCIS has been featured in Manufacturing Chemist article.
Enhancing Biotherapeutic Stability: CARBOGEN AMCIS Featured in PharmTech eBook
Caroline Ailhas, our Pharmaceutical Development Director, contributed her expert...
Solving Problems at CARBOGEN AMCIS towards Lean PDCA (Plan Do Check Act) and A3-report methods
The A3 method is a systematic approach to problem-solving widely used within the...
Speciality Chemicals Magazine: CARBOGEN AMCIS featured on High Potency APIs
CARBOGEN AMCIS has been featured in the latest edition of Speciality Chemicals M...
CDMO Europe: how to choose yours?
Choosing the appropriate Contract Development and Manufacturing Organization (CD...
MedinCell X CARBOGEN AMCIS: A Partnership for Global Health
Join us as we delve into the inspiring partnership between MedinCell and CARBOGE...
CARBOGEN AMCIS receives CDMO Leadership Awards 2024
We are honored to announce that CARBOGEN AMCIS has been awarded across four cate...
Driving Change: The Sustainable Trajectory of CARBOGEN AMCIS Manchester
Explore how CARBOGEN AMCIS Manchester is leading the way in sustainable practice...
5 things to consider when choosing your drug product CDMO
How to choose the right CDMO partner for drug product? Discover our TOP 5 things...
Interview with Jeroen de Jong, Manager Risk & Compliance
Find more informations on our last CSR report dedicated to our Veenendaal site i...
ACS OMEGA Publication: CARBOGEN AMCIS Researchers Contribute to Protein Conjugation Advancements
CARBOGEN AMCIS Researchers, Dr. Artem Osypenko and Dr. Igor Dovgan, Publish Adva...
Advancing ADC and Drug Product Solutions: CARBOGEN AMCIS Expertise
Watch Episode 2 of our Customer Journey series on CARBOGEN AMCIS Drug Products, ...
Formulation and Development of Injectable Drug Product at CARBOGEN AMCIS
In addition to Drug Substance services, CARBOGEN AMCIS is currently in an on-goi...
Criticality-based Process Data Evaluation: Our tool to navigate process data
Criticality-based process data evaluation substantially accelerates exploration ...
Pushing Boundaries in API Synthesis: Our Journey to Elevate Clazosentan Production Featured in OPR&D...
CARBOGEN AMCIS and Idorsia collaborate on a groundbreaking API synthesis process...
CARBOGEN AMCIS's Journey Featured on PharmaSource Podcast
Exploring CARBOGEN AMCIS's Journey with Stephan Fritschi, CARBOGEN AMCIS Executi...
We're hiring in Production | Wir suchen Mitarbeitende in der Produktion
CARBOGEN AMCIS is currently hiring for a variety of positions in Production! Dis...
Interview with Dr. Gavin Schmid, Head of Environment, Safety & Health
Following the Corporate Social Responsibility report that evaluates our 2022 env...
Simulated Moving Bed chromatography at CARBOGEN AMCIS AG
Find out more about Simulated Moving Bed chromatography process at CARBOGEN AMCI...
Large Scale Metal Scavenging and Associated Decolorization at CARBOGEN AMCIS Shanghai
Discover our new article on Large Scale Metal Scavenging and Associated Decolori...
The Evolution of Flow Chemistry
Dr Samuel Bourne, CARBOGEN AMCIS’ Flow Chemistry scientific and Dr. Franz Amann,...
Bring your future to life at CARBOGEN AMCIS: we're hiring!
CARBOGEN AMCIS is currently hiring for a variety of positions across the organiz...
Q&A with Cor Veldhuizen, CARBOGEN AMCIS’ Global Head of Vitamin D analogues
Cor Veldhuizen, CARBOGEN AMCIS’ Global Head of Vitamin D analogues, explains the...
Bioconjugation & Antibody Drug Conjugates Brochure
Learn more about our Bioconjugation & Antibody Drug Conjugates services at C...
Development and Aseptic Production of Drug Products Brochure
Learn more about Development and Aseptic Production of Drug Products at CARBOGEN...
ICH Stability Studies and Integrated Analytical Services Brochure
Learn more about our ICH Stability Studies and Integrated Analytical Services at...
Cholesterol & Vitamin D Analogs Brochure
Learn more about Cholesterol & Vitamin D Analogs Products at CARBOGEN AMCIS
CARBOGEN AMCIS 2023 Spring Science Day Event
The 2023 spring Science Day event was held March 23 at the Gasthof zum Schützen ...
CARBOGEN AMCIS expands capacity for parenteral drug manufacturing
Our new state-of-the-art facility will allow for larger capacities to supply our...
CARBOGEN AMCIS Drug Products New Site: Opening Ceremony video
Our new dedicated site for the production of liquid and lyophilised sterile drug...
Saint-Beauzire: opening ceremony of our new site in France dedicated to Drug Products
The inauguration of our new production site dedicated to the manufacture of drug...
Our locations and services in video
Watch our locations and services video to better understand our services!
New Drug Products Facility
CARBOGEN AMCIS expands capacity for parenteral drug manufacturing.
Panel discussion on HPAPIs - Chemistry Today September/October 2022
Mara Guzzetti, General Manager Switzerland, CARBOGEN AMCIS and Anton Gayring, Se...
Customer Journey at CARBOGEN AMCIS
Watch the first episode of our new "Customer Journey" series and learn how CARBO...
Interview Chemtogether 2022 Dr. Luca Mannocci
Find more about our Manager of Antibody Drug Conjugates
Regierungsrat Dieter Egli visits CARBOGEN AMCIS in Hunzenschwil
Dieter Egli, Regierungsrat of canton Aargau, visits inauguration of new analytic...
Discovery & Development of a New ADC
During the BOS Basel 2022 Heidelberg Pharma and CARBOGEN AMCIS presented their c...
"How the drug services industry found itself prepared for a pandemic"
Mark Griffiths, CEO, speaks about the current challenges in the industry.
"CARBOGEN AMCIS accélère dans le domaine du médicament injectable"
Article in French about the expansion in France and the new site Riom 2.
Interview Chemtogether 2021 Dr. Volker Wolfart
Interview in German with Dr. Volker Wolfart an insight of what it is like to wor...
Teaser Riom 2 - Episode 2: The work is continuing
CARGOGEN AMCIS is expanding in France and the work is continuing!
CARBOGEN AMCIS Virtual DCAT Member Company Announcement Forum - Mark Griffiths
Watch full CARBOGEN AMCIS presentation at the Virtual DCAT Member Company Announ...
Data Integrity: A Key Topic for CARBOGEN AMCIS as a leading API Supplier
Data Integrity is an aspect which concerns all areas involved in a GMP regulated...
Mastering the Supply Chain
After intense research investigations Heidelberg Pharma found a unique access to...
"CARBOGEN AMCIS développe des médicaments injectables"
Article in French about the expansation Riom 2 of the second production plant fo...
"CARBOGEN AMCIS lance une nouvelle unité de fabrication de produits injectables"
Article in French about the expansion of Riom 2 in Saint-Beauzire (Puy-de-Dôme).
"Les travaux de la nouvelle usine pharmaceutique CARBOGEN AMCIS"
Article in French about the expansion of Riom 2 in Saint-Beauzire (Puy-de-Dôme).
Teaser Riom 2 project - Work has begun
CARGOGEN AMCIS is expanding in France and the work has begun!
Radio SRF1 - Regionaljournal Aargau Solothurn
Vice President Alan Fischer & Vice President Stephan Fritschi on Radio SRF1.
"140 neue Jobs am Standort Hunzenschwil"
Article in German about the progressing planning process for the expansion of th...
Making a step change
Article about the API facility in Hunzenschwil with an interview of Mark Griffit...
"Der lange Weg zur Chemiefabrik in Hunzenschwil"
Article in German about the update of the construction in Hunzenschwil, Switzerl...
Development & Aseptic Production of Drug Products
Learn more about our Development & Aseptic Production of Drug Products servi...
Interview Nobel Laureate Prof. Lehn
Discover the Interview of Nobel Laureate Prof. Lehn explaining his collaboration...
Interview Pascal Villemagne, VP Sales and Marketing at CARBOGEN AMCIS, for "Paroles d'experts"
Pascal Villemagne speaks about CARBOGEN AMCIS expansion plans in France and Swit...
"Dreistellige Millioneninvestition"
Article in German about CARBOGEN AMCIS' investment in Hunzenschwil, Switzerland.
"CARBOGEN AMCIS to expand pharmaceutical services in Europe"
Article about CARBOGEN AMCIS' expansion in France and Switzerland.
"Grosse Investitionen im Kampf gegen Krebs"
Article in German about CARBOGEN AMCIS in Switzerland, incl. interview with Dr. ...
Panel Discussion on Flow Chemistry
Franz Amman, Senior Scientist Development, and Samuel Bourne, Scientific Special...
Regierungsrat Basel-Landschaft besucht die CARBOGEN AMCIS AG
German article about Regierungsrat BL visiting CARBOGEN AMCIS in June 2020
Development and Scale-up of a Miyaura Borylation Process
The following case study is one example of how CARBOGEN AMCIS helps customers to...
CARBOGEN AMCIS Passion For Science
Watch our corporate video to better understand our services!
Technology Transfer
Learn more about our efficient and effective technology transfer process with a ...
Thermal Overman Rearrangement of a Glucal Derivative
Franz Amann about CARBOGEN AMCIS' flow chemistry capabilities.
Our approach in Drug Product Development & Manufacture
Pharmaceutical development of drug products is a complex and challenging process...
Custom Development and Manufacture of Fine Chemicals
Capabilities and equipment at CARBOGEN AMCIS in Manchester.
Antibody Drug Conjugates and Bioconjugation made in Bubendorf
This article provides an overview of ADC & Bioconjugation Services offered i...
Investigating Human Error in Pharmaceutical Manufacturing
Lecture which took place at ILMAC Lausanne, Forum on October 4, 2017 by Dr. Cars...
Highly Potent Active Pharmaceutical Ingredients at CARBOGEN AMCIS
Dr. Anton Gayring, Senior Head of Development, speaks about Highly Potent API at...
CARBOGEN AMCIS Apprenticeship Diaries - Eveline
In her own words, Eveline shares her experience as an apprentice at CARBOGEN AMC...
CARBOGEN AMCIS Apprenticeship Diaries - Philip
In his own words, Philip shares his experience as an apprentice at CARBOGEN AMCI...
Synthesis and Structural Properties of Bridged 1,8‐Diazacyclotetradeca‐4,11‐diynes
The synthesis of 1,8‐diazacyclotetradeca‐4,11‐diyne was accomplished by reaction...
Cage-like molecules with triple bonds
The syntheses of 1,8-diazacyclotetradeca-4,11-diyne and 1,8-diazabicyclo[6.6.6]e...
A bridgehead amine with planar nitrogens
The synthesis of 1,8-diazabicyclo[ 6.6.4]octadeca-4,11,16-triyne (3) has been ac...
Reactions of 1,8‐Diheterocyclotetradeca‐4,11‐diynes
The following monocyclic and bicyclic 14‐membered diynes were treated with [ CpC...
Syntheses and properties of N,N′-bridged-1,10-diazabicyclooctadeca-5,14-diynes
The conformations and properties of 1,(k + 2)-diazabicyclo[ k.l.m]alkanes are re...
Reaction of N,N'-bridged 1,10-diazacyclooctadeca-5,14-diynes with [ CpCo(cod)]
The reaction of N,N′-bridged 1,10-diazacyclooctadeca-5,14-diynes 1a–d with [ CpC...
Synthesis of (S)-1-Boc-2,5-dihydro-1H-pyrrole-2- carboxylic Acid
A short and efficient synthesis of (S)-1-Boc-2,5-dihydro-1H-pyrrole-2-carboxylic...
Example of a Stereoselective Synthesis in Industrial API Manufacture
Stereochemistry is an important topic not only in academic research, but also in...
Process Development and Multikilogram Syntheses of XL228
Route scouting, process development, and multikilogram syntheses of an IGF-1R/Sr...
Safety Assessment for the Scale-up of an Oxime Reduction
A pilot-plant process is described for the reduction of 2-allyl cyclohexanone ox...
Identification of a 1,2,4,5-Tetraoxane Antimalarial Drug-Development Candidate
From a library of over 150 1,2,4,5‐tetraoxanes, the candidate RKA 182 was select...
Scale-up of a high temperature Claisen synthesis
Control of trace inorganics and an understanding of reaction kinetics and impuri...
Process Optimization for GSK369796 (N-tert-Butyl Isoquine)
An improved process to the novel 4-aminoquinoline antimalarial GSK369796 is desc...
HMG-CoA Reductase Inhibitor
Development work toward an enabling synthesis of preparative scale batches of an...
2-(Diethylamino)ethanethiol
A new reagent for the deprotection of aromatic methyl ethers, 2-(diethylamino)et...
Chiroptical Properties of some Monoazapentahelicenes
Three closely related previously synthesized monoaza[ 5]helicenes have been reso...
Synthesis of 2-Amino-8-hydroxyquinoline
The first safe and efficient synthesis of the important building block 2-amino-8...
Interview with Emad El Sayed, Ph.D.
Emad El Sayed, Manager PR&D, speaks about career opportunities at CARBOGEN A...
Process scale-up of cis-N-Benzyl-3-methylamino-4-methylpiperidine
The synthesis of cis-N-benzyl-3-methylamino-4-methylpiperidine via hydroboration...
Large scale preparation of 3-Methyl-4H-[ 1, 2, 4]oxadiazol-5-one
The development of a safe and practical process for the potassium and sodium sal...
CARBOGEN AMCIS Veenendaal - Solvent-free in 2030?
Solvent-free in 2030 - Utopia or Breakthrough? Article about CARBOGEN AMCIS Veen...
Interview For Chemtogether 2019 Dr. Volker Wolfart
Interview with Dr. Volker Wolfart, an insight of what it is like to work at CARB...
Interview Chemtogether 2017 Dr. Jonas Bürgler
Interview in German with Dr. Jonas Bürgler, an insight of what it is like to wor...
Chromatography Services offered in Switzerland
CARBOGEN AMCIS' preparative chromatography capabilities have been developed and ...
Process Development in China at CARBOGEN AMCIS + Case Study
Harry Wong, Senior Head of Development, speaks about Process Development at our ...
Chemical & Engineering News - "Pharmaceutical Outsourcing"
Article "Outsourcing tales from the drug services industry trenches"
Panel Discussion on Flow Chemistry
Franz Amman Ph.D., Senior Scientist at CARBOGEN AMCIS, speaks about Flow Chemist...
5 Minutes Interview with Dishman CARBOGEN AMCIS
Five Minutes at CPhI Worldwide with Mark Griffiths (Global CEO) & Pascal Vil...
Pharma's Almanac
Article "Continuous Manufacturing: To Be Continued..." in Pharma's Almanac.
Interview with Mark Griffiths – Group CEO, Dishman Group
“Our sole focus is on ensuring that customer needs are addressed as swiftly and ...